Generic Name and Formulations:
Pindolol 5mg, 10mg; tabs.
Various generic manufacturers
Indications for Pindolol:
Initially 5mg twice daily. May increase after 3–4 wks in 10mg increments; max 60mg daily.
Asthma. Severe bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock.
Severe COPD. Ischemic heart disease or failure. Renal or hepatic dysfunction. Diabetes. Hyperthyroidism. Surgery. Avoid abrupt cessation. Pregnancy (Cat.B). Nursing mothers: not recommended.
Hypotension with prazosin, reserpine. Adjust antidiabetic medications. Caution with verapamil, catecholamine-depleting drugs. May block epinephrine, β-agonists. Potentiated by thioridazine.
Muscle pain, insomnia, dizziness, fatigue, anxiety, joint pain, edema, dyspnea, GI upset, paresthesias, chest pain, pruritus, bradycardia, bronchospasm, heart failure or block, angina.
Formerly known under the brand name Visken.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Short Forms of Parent General Behavior Inventory Reliable at Identifying Youth Mood Symptoms
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Digital Media Engagement Associated With ADHD Symptoms in Adolescents
- Strong Social Networks May Mitigate the Effects of Childhood Adversity
- Unexpected Effect of Substance Use Disorders on Recovery From Bipolar Depression
- Republican Opposition to Obamacare: What's Done, What's to Come
- Early Childhood Out-of-Home Placement Associated With Adverse Outcomes in Adulthood
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Integrating Treatments for Opioid Use Disorder and Infectious Diseases